Patients preferences in treatment for neovascular age-related macular degeneration in clinical routine
British Journal of Ophthalmology, 05/14/2012Finger R et al.
Time trade–off (TTO) performed best in this sample of elderly neovascular age–related macular degeneration (nvAMD) patients undergoing anti–VEGF therapy. Better or worse eye treatment was not associated with a change in reported utilities or visual functioning in patients with newly diagnosed nvAMD. Directly elicited, vision–specific utilities gained with TTO seem to be sensitive to a change in vision status.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.